Protagonist Therapeutics, Inc. (PTGX)
92.36
-3.06
(-3.21%)
USD |
NASDAQ |
Mar 13, 16:00
92.06
-0.30
(-0.32%)
After-Hours: 20:00
Protagonist Therapeutics Market Cap : 5.893B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 582.04B |
| Glaukos Corp. | 5.635B |
| Krystal Biotech, Inc. | 7.228B |
| Olema Pharmaceuticals, Inc. | 1.010B |
| ACADIA Pharmaceuticals, Inc. | 3.514B |
Market Cap Related Metrics
| PS Ratio | 127.59 |
| Price to Book Value | 9.587 |
| Price to Free Cash Flow | 104.69 |
| Price | 92.36 |
| Earnings Yield | -2.21% |